Advances in hyperuricemia drugs for gout treatment
10.13699/j.cnki.1001-6821.2017.09.023
- VernacularTitle:抗痛风相关的高尿酸血症药物的研究进展
- Author:
Qing CHEN
1
;
Yuan TIE
;
Yong-Chuan HU
;
Lei LIU
Author Information
1. 北京医院国家老年医学中心
- Keywords:
xanthine oxidoreductase inhibitor;
purine nucleoside phosphorylase inhibitor;
hyperuricemia;
gout
- From:
The Chinese Journal of Clinical Pharmacology
2017;33(9):853-856
- CountryChina
- Language:Chinese
-
Abstract:
Persistent hyperuricemia is currently the most common cause of gout.New medications targeting the urate transporters in renal proximal tubule epithelial cells have become hot topics for gout treatment.The latest progress in hyperuricemia drugs for gout treatment was reviewed in this paper.
